EUVIMEDEUVIMED entdecken
Open Access

Deep learning identifies TP-41 for methylglyoxal scavenging in Alzheimer's treatment

Aron Park, Seong-Min Hong, Yeeun Lee, Jungeun Lee, Seunggyu Jeon, Seung-Yong Seo, Jinhyuk Lee, Seon-Hyeok Kim, Eun Ji Ko, Hae Ran Lee, Sang Heon Jung, Munhyung Bae und 4 weitere

Theranostics · 2026

DOI: 10.7150/thno.111550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Aron Park und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology (GAIHST), Gachon University, Incheon, 2199…. Hauptthemen laut MEDLINE: Alzheimer Disease, Pyruvaldehyde, Deep Learning. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Increased levels of advanced glycation end products (AGEs) have been observed in the brain tissues of patients with Alzheimer's disease (AD). Methylglyoxal (MGO) is a potent precursor of AGEs. To date, there have been no reports of utilizing deep learning (DL) technologies to target MGO scavengers for the development of AD therapeutics. Therefore, DL-driven approaches may play a crucial role in identifying potential MGO scavengers and candidates for Alzheimer's treatment.

Methods

We developed "DeepMGO," a novel DL-based MGO scavenging activity prediction model, trained on 2,262 MGO scavenging activity assays from 660 compounds. Using this approach, we identified and validated TP-41 as a potential MGO scavenger in a mouse model of memory impairment.

Results

DeepMGO demonstrated robust predictive performance and identified novel compounds with high MGO scavenging activity. TP-41 ameliorated depression symptoms and memory deficits in mouse models.

Conclusions

Using DeepMGO, we identified TP-41 as a potential therapeutic agent for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePyruvaldehydeDeep LearningAnimalsMiceDisease Models, AnimalGlycation End Products, AdvancedHumansMaleMemory DisordersMice, Inbred C57BL

Stichwörter der Autor:innen

Alzheimer's diseasedeep learningdrug discoverymemory impairmentmethylglyoxal

Substanzen

PyruvaldehydeGlycation End Products, Advanced

Autor:innen und Institutionen

  • Department of Health Sciences and Technology, Gachon Advanced Institute for Health Sciences and Technology (GAIHST), Gachon University, Incheon, 21999, Korea.
  • Division of Food Science and Technology, Gyeongsang National University, Jinju, Gyeongnam 52828, Korea.
  • Department of Genome Medicine and Science, Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, 21565, Korea.
  • College of Pharmacy and Gachon Institute of Pharmaceutical Science, Gachon University, 191, Hambakmoe-ro, Yeonsu-gu, Incheon 21936, Korea.
  • Genome Editing Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea.
  • MetaCen Therapeutics Company, Changnyong-daero 256 Beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do 16229, Korea.

Zitieren

APA

Park, A., Hong, S. M., Lee, Y., Lee, J., Jeon, S., Seo, S. Y., Lee, J., Kim, S. H., Ko, E. J., Lee, H. R., Jung, S. H., Bae, M., Kang, M. C., Park, M. G., Nam, S., & Kim, S. Y. (2026). Deep learning identifies TP-41 for methylglyoxal scavenging in Alzheimer's treatment. Theranostics. https://doi.org/10.7150/thno.111550

Vancouver

Park A, Hong SM, Lee Y, Lee J, Jeon S, Seo SY, et al. Deep learning identifies TP-41 for methylglyoxal scavenging in Alzheimer's treatment. Theranostics. 2026. doi:10.7150/thno.111550

BibTeX
@article{Park2026,
  author = {Park, Aron and Hong, Seong-Min and Lee, Yeeun and Lee, Jungeun and Jeon, Seunggyu and Seo, Seung-Yong and Lee, Jinhyuk and Kim, Seon-Hyeok and Ko, Eun Ji and Lee, Hae Ran and Jung, Sang Heon and Bae, Munhyung and Kang, Min Cheol and Park, Myoung Gyu and Nam, Seungyoon and Kim, Sun Yeou},
  title = {Deep learning identifies TP-41 for methylglyoxal scavenging in Alzheimer's treatment},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.111550}
}
Kostenlos starten →